This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Travelers Companies Inc., a holding company, is principally engaged, through its subsidiaries, in providing a wide variety of property and casualty insurance and surety products and services to businesses, organizations and individuals in the United States. and select international markets. Travelers operates its business through three segments: The Business Insurance segment, The Personal Insurance segment, and The Bond & Specialty Insurance segment.
TRV or CCCS: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TRV vs. CCCS: Which Stock Is the Better Value Option?
Skyward Specialty Trading at a Premium: How Should You Play the Stock?
by Zacks Equity Research
Focus on high-return areas, prudent pricing, better retention and shifting of the business mix toward more profitable lines poise SKWD for growth.
PGR's November Earnings Improve: Should You Buy or Hold the Stock?
by Tanuka De
Progressive stock seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.
ROOT Stock Skyrockets 627% YTD: Time to Buy Despite Premium Valuation?
by Tanuka De
Despite its expensive valuation, given its focus on driving growth, its price appreciation and its VGM Score of B, you can bet on ROOT stock.
TRV Stock Trading at a Premium to the Industry: Will You Still Buy It?
by Tanuka De
Despite its premium valuation, Travelers remains one of investors' favorites for addition to their portfolio.
Top Research Reports for Netflix, BP & Constellation Energy
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Netflix, Inc. (NFLX), BP p.l.c. (BP) and Constellation Energy Corporation (CEG), as well as two micro-cap stocks, Tucows Inc. (TCX) and Bridger Aerospace Group Holdings, Inc. (BAER).
Here's Why Travelers (TRV) is a Strong Growth Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is The Travelers Companies (TRV) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Travelers (TRV) and CrossFirst Bankshares (CFB) have performed compared to their sector so far this year.
Is The Travelers Companies (TRV) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Growth Stocks From P&C Insurance Space to Enhance Your Portfolio
by Sushmita Sarker
Given the prospects of the Property and Casualty Insurance industry, ALL, TRV, ROOT and MCY have the potential to generate better returns than other player.
Here's Why Travelers (TRV) is a Strong Momentum Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Mercury General Corporation (MCY) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Mercury General (MCY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Arch Capital (ACGL) Up 2.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Arch Capital (ACGL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Travelers (TRV) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
AFG Rallies 24.4% YTD but Lags Industry: How to Play the Stock
by Zacks Equity Research
American Financial gains on the back of new business opportunities, increased exposures, a better renewal rate environment and effective capital deployment.
3 Reasons Growth Investors Will Love Travelers (TRV)
by Zacks Equity Research
Travelers (TRV) could produce exceptional returns because of its solid growth attributes.
Chubb Rallies 29% YTD but Lags Industry: How to Play the Stock
by Tanuka De
Investors who already hold CB stock should retain it, as this insurance behemoth is unlikely to disappoint. New investors can wait for a better entry point.
Travelers (TRV) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Travelers (TRV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TRV vs. CCCS: Which Stock Is the Better Value Option?
by Zacks Equity Research
TRV vs. CCCS: Which Stock Is the Better Value Option?
Why Is First American Financial (FAF) Up 3.9% Since Last Earnings Report?
by Zacks Equity Research
First American Financial (FAF) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Travelers (TRV) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
CNA Stock Near 52-Week High: Here's What Investors Should Know
by Zacks Equity Research
CNA Financial stock is riding on solid premium writing underwriting expertise, solid balance sheet, capital deployment and growth projections.
RLI Corp. (RLI) Up 9.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
RLI Corp. (RLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is The Travelers Companies (TRV) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Travelers (TRV) and CrossFirst Bankshares (CFB) have performed compared to their sector so far this year.
Progressive's October Earnings Rise: Here's How to Play the Stock
by Tanuka De
PGR seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.